Apoptosis of tumor infiltrating effector TIM-3+CD8+ T cells in colon cancer-Reference-Cited by-同舟云学术

Apoptosis of tumor infiltrating effector TIM-3+CD8+ T cells in colon cancer

Published:2015-10-23 Issue:1 Volume:5 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Kang Chiao-Wen,Dutta Avijit,Chang Li-Yuan,Mahalingam Jayashri,Lin Yung-Chang,Chiang Jy-Ming,Hsu Chen-Yu,Huang Ching-Tai,Su Wan-Ting,Chu Yu-Yi,Lin Chun-Yen

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep15659.pdf

Reference50 articles.

1. Pages, F. et al. Effector memory T cells, early metastasis and survival in colorectal cancer. N. Engl. J. Med. 353, 2654–2666 (2005).

2. Zhang, L. et al. Intratumoral T cells, recurrence and survival in epithelial ovarian cancer. N. Engl. J. Med. 348, 203–213 (2003).

3. Yamada, N. et al. CD8+ tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection. Cancer Immunol. Immunother. 59, 1543–1549 (2010).

4. Blank, C., Gajewski, T. F. & Mackensen, A. Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy. Cancer Immunol. Immunother. 54, 307–314 (2005).

5. Dong, H. et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8, 793–800 (2002).

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive study on the prognostic value and clinicopathological significance of different immune checkpoints in patients with colorectal cancer: a systematic review and meta-analysis;Current Therapeutic Research;2024-09

2. Soluble immune checkpoints: implications for cancer prognosis and response to immune checkpoint therapy and conventional therapies;Journal of Experimental & Clinical Cancer Research;2024-05-31

3. Apoptosis, a Metabolic “Head-to-Head” between Tumor and T Cells: Implications for Immunotherapy;Cells;2024-05-27

4. Plasma Gelsolin Inhibits Natural Killer Cell Function and Confers Chemoresistance in Epithelial Ovarian Cancer;Cells;2024-05-24

5. Promising immunotherapy targets: TIM3, LAG3, and TIGIT joined the party;Molecular Therapy: Oncology;2024-03